32505 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 24
00:32 UTC
|
HSBA
HSBC
|
◎ Target | firm only | Neutral | GBX 1,570→ GBX 1,640+4.5% |
|
Sep 24
00:32 UTC
|
HII
Huntington Ingalls Industries
|
◎ Target | Douglas Harned ★★★☆☆ #2245 | Market Perform | $341.00→ $327.00-4.1% |
|
Sep 24
00:32 UTC
|
HBAN
Huntington Bancshares
|
◎ Target | Brian Foran ★★★☆☆ #1508 | Buy | $20.00→ $19.00-5.0% |
|
Sep 24
00:32 UTC
|
HAS
Hays
|
◎ Target | firm only | Neutral | GBX 33→ GBX 65+97.0% |
|
Sep 24
00:32 UTC
|
GTE
Gran Tierra Energy
|
◎ Target | firm only | C$17.50→ C$18.50+5.7% | |
|
Sep 24
00:32 UTC
|
GS
The Goldman Sachs Group
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $1,200.00→ $1,050.00-12.5% |
|
Sep 24
00:32 UTC
|
GD
General Dynamics
|
◎ Target | Douglas Harned ★★★☆☆ #2245 | Market Perform | $421.00→ $407.00-3.3% |
|
Sep 24
00:32 UTC
|
FSLY
Fastly
|
◎ Target | Rudy Kessinger ★★★☆☆ #1163 | Neutral | $21.00→ $23.00+9.5% |
|
Sep 24
00:32 UTC
|
FSLY
Fastly
|
◎ Target | Almas Almaganbetov ★★★★☆ #642 | Buy | $32.00→ $37.00+15.6% |
|
Sep 24
00:32 UTC
|
FSLY
Fastly
|
◎ Target | Tal Liani ★★★☆☆ #1950 | Underperform | $20.00→ $22.00+10.0% |
|
Sep 24
00:32 UTC
|
FITB
Fifth Third Bancorp
|
◎ Target | Brian Foran ★★★☆☆ #1508 | Buy | $64.00→ $63.00-1.6% |
|
Sep 24
00:32 UTC
|
FDR
Founders Metals
|
◎ Target | firm only | C$8.00→ C$9.00+12.5% | |
|
Sep 24
00:32 UTC
|
ERO
Ero Copper
|
◎ Target | firm only | C$52.00→ C$56.00+7.7% | |
|
Sep 24
00:32 UTC
|
EQT
EQT
|
◎ Target | Scott Gruber ★★★★☆ #785 | Buy | $67.00→ $68.00+1.5% |
|
Sep 24
00:32 UTC
|
ELE
Elemental Altus Royalties
|
◎ Target | firm only | Outperform | C$33.00→ C$36.00+9.1% |
|
Sep 24
00:32 UTC
|
ELE
Elemental Altus Royalties
|
◎ Target | firm only | C$30.00→ C$36.00+20.0% | |
|
Sep 24
00:32 UTC
|
DPZ
Domino's Pizza
|
◎ Target | Gregory Francfort ★★★☆☆ #1031 | Neutral | $440.00→ $325.00-26.1% |
|
Sep 24
00:32 UTC
|
CNR
Canadian National Railway
|
◎ Target | firm only | Sec→ r Perform | C$192.00→ C$190.00-1.0% |
|
Sep 24
00:32 UTC
|
CNI
Canadian National Railway
|
◎ Target | Ken Hoexter ★★☆☆☆ #2298 | Buy | $146.00→ $143.00-2.1% |
|
Sep 24
00:32 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Michael Schmidt ★★☆☆☆ #2317 | Buy | $4.00 |
|
Sep 24
00:32 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Reni J. Benjamin not yet tracked | Market Outperform | $4.00 |
|
Sep 24
00:32 UTC
|
CMI
Cummins
|
◎ Target | Tami Zakaria ★★★☆☆ #2030 | Neutral | $690.00→ $600.00-13.0% |
|
Sep 24
00:32 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★☆☆☆ #2508 | Overweight | $50.00→ $57.00+14.0% |
|
Sep 24
00:32 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Thomas Smith ★★★★☆ #365 | Outperform | $70.00→ $88.00+25.7% |
|
Sep 24
00:32 UTC
|
CGNX
Cognex
|
◎ Target | Richard Eastman not yet tracked | Neutral | $78.00→ $70.00-10.3% |
|
Sep 24
00:32 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Brian Foran ★★★☆☆ #1508 | Hold | $80.00→ $77.00-3.8% |
|
Sep 24
00:32 UTC
|
BSVN
Bank7
|
◎ Target | Woody Lay not yet tracked | Outperform | $56.00→ $62.00+10.7% |
|
Sep 24
00:32 UTC
|
BP
BP
|
◎ Target | firm only | Neutral→ Overweight | GBX 550→ GBX 675+22.7% |
|
Sep 24
00:32 UTC
|
BOKU
Boku
|
◎ Target | firm only | Buy | GBX 200→ GBX 210+5.0% |
|
Sep 24
00:32 UTC
|
BFAM
Bright Horizons Family Solutions
|
◎ Target | Toni Kaplan ★★★☆☆ #1175 | Underweight | $68.00→ $66.00-2.9% |
|
Sep 24
00:32 UTC
|
BARC
Barclays
|
◎ Target | firm only | Neutral | GBX 510→ GBX 500-2.0% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Tristan Thomas-Martin not yet tracked | Outperform | $4,000.00→ $3,500.00-12.5% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | David Bellinger ★★★☆☆ #1462 | Neutral | $3,200.00→ $3,000.00-6.2% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Justin Kleber ★★☆☆☆ #2836 | Neutral | $3,600.00→ $3,400.00-5.6% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Scott Stember ★★☆☆☆ #2262 | Buy | $4,023.00→ $3,850.00-4.3% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Max Rakhlenko ★★★☆☆ #1574 | Buy | $3,500.00→ $3,400.00-2.9% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Michael Baker ★★★☆☆ #1359 | Buy | $3,750.00→ $3,500.00-6.7% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Bobby Griffin ★★★★☆ #525 | Strong-Buy | $4,000.00→ $3,700.00-7.5% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Scot Ciccarelli ★★★☆☆ #1788 | Buy | $3,817.00→ $3,648.00-4.4% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Steven Forbes ★★★★☆ #381 | Buy | $4,000.00→ $3,750.00-6.2% |
|
Sep 24
00:32 UTC
|
AZO
AutoZone
|
◎ Target | Seth Sigman ★★★☆☆ #1884 | Overweight | $3,637.00→ $3,400.00-6.5% |
|
Sep 24
00:32 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Srikripa Devarakonda ★★★★☆ #938 | Buy | $200.00→ $285.00+42.5% |
|
Sep 24
00:32 UTC
|
AXP
American Express
|
◎ Target | Brian Foran ★★★☆☆ #1508 | Buy | $375.00→ $370.00-1.3% |
|
Sep 24
00:32 UTC
|
ANAB
AnaptysBio
|
◎ Target | David Risinger ★★★★☆ #942 | Outperform | $90.00→ $81.00-10.0% |
|
Sep 24
00:32 UTC
|
AMRZ
Amrize
|
◎ Target | Jon Bell not yet tracked | Buy | $64.00→ $56.00-12.5% |
|
Sep 24
00:32 UTC
|
ALLY
Ally Financial
|
◎ Target | Brian Foran ★★★☆☆ #1508 | Buy | $51.00→ $50.00-2.0% |
|
Sep 24
00:32 UTC
|
AGX
Silver X Mining
|
◎ Target | firm only | C$1.60→ C$2.50+56.2% | |
|
Sep 24
00:32 UTC
|
ACN
Accenture
|
◎ Target | Keith Bachman ★★★☆☆ #1300 | Market Perform | $150.00→ $200.00+33.3% |
|
Sep 24
00:32 UTC
|
ACHC
Acadia Healthcare
|
◎ Target | Whit Mayo ★★★★☆ #341 | Market Perform | $30.00→ $33.00+10.0% |
|
Sep 24
00:32 UTC
|
ABF
Associated British Foods
|
◎ Target | firm only | Sec→ r perform | GBX 1,550→ GBX 1,520-1.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.